Skip to main content

Table 8 Rate of antibiotic Use in the IFNα1b group and the control group (%)

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 

FAS

PPS

IFNα1b Group

Control Group

IFNα1b Group

Control Group

Use of Item antibiotics

5 (6.6%)

8 (9.2%)

5 (7.2%)

7 (8.5%)

Use of antibiotics

71 (93.4%)

79 (90.8%)

64 (92.8%)

75 (91.5%)

P

0.745

 

1.000